HONOLULU, Oct. 5, 2025 /PRNewswire/ — Preliminary findings for dopaminergic cell transplantation have reported positive trends towards safety and efficacy for people with Parkinson’s disease (PD), according to two studies released at the International Congress […]
HONOLULU, Oct. 5, 2025 /PRNewswire/ — Preliminary findings for dopaminergic cell transplantation have reported positive trends towards safety and efficacy for people with Parkinson’s disease (PD), according to two studies released at the International Congress […]
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson’s disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel […]
